UK markets closed
NIKKEI 225
38,835.10 +599.03 (+1.57%) HANG SENG
18,479.37 -98.93 (-0.53%) CRUDE OIL
78.41 -0.07 (-0.09%) GOLD FUTURES
2,323.10 -8.10 (-0.35%) DOW
38,859.98 +7.71 (+0.02%) Bitcoin GBP
50,276.50 -395.08 (-0.78%)
Enlivex Therapeutics Ltd. (1BT.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 08:02AM CEST. Market open.
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 27.45M |
| Enterprise value | 3.02M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 1.00 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -0.12 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.05 |
| 52-week change 3 | -44.78% |
| S&P500 52-week change 3 | 25.77% |
| 52-week high 3 | 3.9200 |
| 52-week low 3 | 1.1700 |
| 50-day moving average 3 | 2.7506 |
| 200-day moving average 3 | 2.1961 |
Share statistics
| Avg vol (3-month) 3 | 82 |
| Avg vol (10-day) 3 | N/A |
| Shares outstanding 5 | 18.81M |
| Implied shares outstanding 6 | 19.06M |
| Float 8 | 14.55M |
| % held by insiders 1 | 11.67% |
| % held by institutions 1 | 8.93% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:8 |
| Last split date 3 | 06 Mar 2019 |
Financial highlights
Currency in USD.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -30.09% |
| Return on equity (ttm) | -66.88% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -24.32M |
| Net income avi to common (ttm) | -29.07M |
| Diluted EPS (ttm) | -1.4500 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 27.32M |
| Total cash per share (mrq) | 1.47 |
| Total debt (mrq) | 1.03M |
| Total debt/equity (mrq) | 3.43% |
| Current ratio (mrq) | 5.57 |
| Book value per share (mrq) | 1.62 |
Cash flow statement
| Operating cash flow (ttm) | -23.52M |
| Levered free cash flow (ttm) | -17.77M |
© 2024 Yahoo. All rights reserved.